Hubei Biocause Pharmaceutical Co., Ltd. is a high-risk pharmaceutical company in China. Specializing in life insurance, health insurance, and medicine, the company generates revenue through premiums. With a risk rating score of 39.5, investors should closely monitor the company's ESG score for environmental, sustainability, and governance practices.